These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. One of the most difficult management problems in surgery is pseudomyxoma peritonei. Foreword. Wells SA Curr Probl Surg; 2008 Aug; 45(8):521. PubMed ID: 18590841 [No Abstract] [Full Text] [Related]
3. Pseudomyxoma peritonei: review on a cluster of peritoneal mucinous diseases. Jacquemin G; Laloux P Acta Chir Belg; 2005 Apr; 105(2):127-33. PubMed ID: 15906901 [TBL] [Abstract][Full Text] [Related]
5. Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei--a report of 103 procedures. Smeenk RM; Verwaal VJ; Zoetmulder FA Eur J Surg Oncol; 2006 Mar; 32(2):186-90. PubMed ID: 16303281 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive study of ovarian metastases in young women with peritoneal pseudomyxoma: is a preservation of fertility possible? Elias D; Duchalais E; David A; Dartigues P; Duvillard P; Poirot C; Goéré D Eur J Surg Oncol; 2013 Jul; 39(7):748-53. PubMed ID: 23523317 [TBL] [Abstract][Full Text] [Related]
7. Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei. Andréasson H; Graf W; Nygren P; Glimelius B; Mahteme H Eur J Surg Oncol; 2012 Oct; 38(10):962-8. PubMed ID: 22809859 [TBL] [Abstract][Full Text] [Related]
8. Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate. Chua TC; Liauw W; Zhao J; Morris DL Ann Surg; 2011 Apr; 253(4):769-73. PubMed ID: 21475018 [TBL] [Abstract][Full Text] [Related]
9. An Italian Multicentric Phase II study on peritonectomy and intra peritoneal hyperthermic perfusion (IPHP) to treat patients with pseudomyxoma peritonei. Deraco M; De Simone M; Rossi CR; Cavaliere F; Di Filippo F; Vaira M; Piatti P; Kusamura S J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):35-9. PubMed ID: 16767904 [TBL] [Abstract][Full Text] [Related]
11. [Treatment possibilities in malignant pleural and peritoneal effusions and pseudomyxoma peritonei]. Meerpohl HG; Karck U Gynakologe; 1992 Apr; 25(2):89-98. PubMed ID: 1377158 [No Abstract] [Full Text] [Related]
12. Treatment of pseudomyxoma peritonei with two times--cytoreduction and hypertermic antiblastic peritoneal perfusion (HAPP). De Simone M; Scuderi S; Vaira M; Costamagna D; Barone R; Fiorentini G; Dentico P; Caponi A; Ciaccio B; Caponi C; Ferri L; Martini E; Cantini S J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):25-8. PubMed ID: 16767902 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience of pseudomyxoma peritonei in Taiwan with emphasis on the treatment and survival. Huang HC; Huang YS; Shyr YM; Yen SH; Chang FY; Lee SD Hepatogastroenterology; 2002; 49(46):999-1001. PubMed ID: 12143263 [TBL] [Abstract][Full Text] [Related]
15. Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process. Mohamed F; Gething S; Haiba M; Brun EA; Sugarbaker PH J Surg Oncol; 2004 Apr; 86(1):10-5. PubMed ID: 15048674 [TBL] [Abstract][Full Text] [Related]
16. Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases. Carr NJ; Finch J; Ilesley IC; Chandrakumaran K; Mohamed F; Mirnezami A; Cecil T; Moran B J Clin Pathol; 2012 Oct; 65(10):919-23. PubMed ID: 22718846 [TBL] [Abstract][Full Text] [Related]
17. Ten years experience in the treatment of pseudomyxoma peritonei by cytoreduction, peritonectomy and semi-closed hyperthermic antiblastic peritoneal perfusion. De Simone M; Vaira M; Caponi A; Ciaccio B; Fiorentini G; Turrisi G; Ferri L; Buti G In Vivo; 2006; 20(6A):725-7. PubMed ID: 17203755 [TBL] [Abstract][Full Text] [Related]
18. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Moran BJ; Cecil TD Surg Oncol Clin N Am; 2003 Jul; 12(3):585-603. PubMed ID: 14567019 [TBL] [Abstract][Full Text] [Related]